Malaria remains one of the deadliest diseases for children under 5 in Africa – despite vaccination programs and the distribution of mosquito nets. Beyond that, another battle is underway: against drug resistance. At the center of the discussion is a plant that is as valuable as it is controversial.
By Lilaafa Amouzou
For the first time, Brussels is poised to apply its International Procurement Instrument: Chinese manufacturers could be excluded from participating in EU tenders for medical devices with a contract value over five million euros.
By Amelie Richter
In a new report, the EU Commission concludes that European manufacturers of medical devices are being discriminated against in the Chinese procurement market. It now examines whether to restrict market access for Chinese medical devices under the International Procurement Instrument.
By Marc Winkelmann
The sales of Siemens Healthineers in China collapsed in the second quarter. The CEO of the Siemens subsidiary emphasized that measures taken by the authorities to reduce demand were not directed against manufacturers – but against hospital procurement.
By Redaktion Table
The controversial project of an EU-wide clinical evaluation of medicinal products and medical devices (Health Technology Assessment, HTA) is coming to an end after years of wrangling. The agreement reached between Parliament and the Council in the summer has now been formally confirmed by the European Parliament. However, there will be no binding assessment of clinical benefit for all member states.
By Eugenie Ankowitsch
